RA0638

antibody from Oursmab

Targeting: ROR2 BDB, BDB1, NTRKR2

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0638

Provider

Oursmab

Product name

Ozuriftamab (Biosimilar Reference Antibody) (ROR2)

Antibody type

Monoclonal

Description

Ozuriftamab is a humanized IgG1-kappa monoclonal antibody that targets receptor tyrosine kinase-like orphan receptor 2 (ROR2), a transmembrane receptor belonging to the ROR family of receptor tyrosine kinases. As an IgG1 isotype, it is designed to engage immune effector functions such as antibody-dependent cellular cytotoxicity (ADCC). ROR2 is involved in developmental signaling pathways (e.g., Wnt/planar cell polarity) and is often overexpressed in certain cancers, where it may promote tumor progression, metastasis, and treatment resistance.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.